J

Janux Therapeutics

54 employees

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical
Biotechnology
Therapeutics
Health Diagnostics

Date founded

2017

Funding rounds raised

Total raised

$125M

from 9 investors over 9 rounds

J

Janux Therapeutics raised $125M on April 20, 2021

Investors: Surveyor Capital, Logos Global Management, LP, Samsara BioCapital, RA Capital Management, L.P. and OrbiMed Advisors

J

Janux Therapeutics raised $56M on March 3, 2021

Investors: Correlation Ventures, OrbiMed Advisors, Avalon Venture and RA Capital Management, L.P.

FAQ